Taiwan Biomaterial Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	26.02	58.93	-1.73	-10.13	33.76	-47.44
Depreciation & Amortization	15.42	15.7	16.79	16.96	15.98	10.21
Other Amortization	0.93	0.93	0.9	0.91	0.92	0.85
Loss (Gain) From Sale of Assets	-	-	-	-	-	0.04
Stock-Based Compensation	-	-	-	-	-	0.26
Other Operating Activities	-0.31	-0.44	-1	0.82	-0.25	0.01
Change in Accounts Receivable	-13.14	-24.14	2.47	1.65	-13.64	3.53
Change in Inventory	-43.98	-18.75	7.84	-30.64	-7.82	-4.06
Change in Accounts Payable	2.48	15.55	-3.55	4.63	2.79	0.02
Change in Unearned Revenue	-1.5	0.29	0.47	-	-	-0.15
Change in Other Net Operating Assets	31.88	0.7	-3.75	5.65	-2.44	10.44
Operating Cash Flow	17.81	48.77	18.43	-10.16	29.31	-26.29
Operating Cash Flow Growth	-70.89%	164.68%	-	-	-	-
Capital Expenditures	-2.65	-1.44	-3.69	-2.57	-35.67	-28.01
Sale of Property, Plant & Equipment	-	-	-	-	0.07	-
Sale (Purchase) of Intangibles	-1.75	-1.7	-0.96	-0.64	-1.81	-1.69
Investment in Securities	19.96	9.96	24.96	16.97	-88.51	76.89
Other Investing Activities	-7.4	0.13	0.21	0.23	5.37	1.14
Investing Cash Flow	8.17	6.95	20.53	13.98	-120.55	48.34
Long-Term Debt Repaid	-	-4.4	-5.29	-6.89	-7.03	-2.24
Net Debt Issued (Repaid)	-4.42	-4.4	-5.29	-6.89	-7.03	-2.24
Issuance of Common Stock	-	-	-	-	189.78	1.03
Common Dividends Paid	-42	-	-	-8.4	-	-
Other Financing Activities	1.74	1.74	-	-	-	-
Financing Cash Flow	-44.68	-2.66	-5.29	-15.29	182.75	-1.21
Net Cash Flow	-18.7	53.06	33.67	-11.47	91.5	20.84
Free Cash Flow	15.16	47.33	14.74	-12.74	-6.36	-54.3
Free Cash Flow Growth	-74.09%	221.06%	-	-	-	-
Free Cash Flow Margin	8.46%	21.47%	15.26%	-17.49%	-5.00%	-130.31%
Free Cash Flow Per Share	0.36	1.13	0.35	-0.30	-0.16	-1.65
Cash Interest Paid	0.74	0.74	0.8	0.87	0.97	1.03
Cash Income Tax Paid	0.37	0.37	0.21	0.25	0.09	-
Levered Free Cash Flow	7.75	25.66	8.13	-12.64	-60.21	-17.57
Unlevered Free Cash Flow	8.2	26.12	8.63	-12.09	-59.6	-16.93
Change in Working Capital	-24.26	-26.35	3.48	-18.71	-21.1	9.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.